First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Trial StartPositive

AI Analysis

Summary

Ananda Pharma Limited announced the first patient dosed in a clinical trial for chemotherapy induced peripheral neuropathy using a cannabidiol-based medicine. The company is a UK-based biopharmaceutical firm developing regulatory approved cannabidiol medicines for complex chronic conditions.

Clinical Trial Data

Outcome Details

First patient dosed in CIPN clinical trial

Importance:3/10

Sentiment:

0.30

clinical trialcannabidiolCIPNtrial initiationneurology

Related Companies

$TRAX

Read the original article

Published by PR Newswire Clinical Trials on July 17, 2026 8:39 AM

Read Original